Jinkuk Kim, PhD

Jinkuk Kim is an Assistant Professor at KAIST in South Korea. He obtained a B.S. in computer science from KAIST in 2004 and a Ph.D. in Bioinformatics and Integrative Genomics from the Harvard-MIT Division of Health Science and Technology in 2011, advised by David P. Bartel at the Whitehead Institute/MIT/HHMI. He then conducted postdoctoral research at Harvard Medical School with Peter J. Park and Timothy W. Yu. Dr. Kim has made significant contributions in oligonucleotide therapy and rare disease genomics. Notably, with Dr. Yu and colleagues, he contributed to developing milasen, the first fully patient-customized therapy for a rare genetic disease (Kim et al, NEJM 2019). More recently, his team at KAIST, in collaboration with Dr. Yu and colleagues, proposed guidelines for patient-customized ASO therapy (Kim et al, Nature 2023), for which he received the 2023 Paper of the Year Award from the Oligonucleotide Therapeutics Society.